229 related articles for article (PubMed ID: 12550042)
1. [Role of linezolid in antimicrobial therapy].
Carmona PM; Romá E; Monte E; García J; Gobernado M
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
Corti G; Cinelli R; Paradisi F
Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
4. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
6. Oxazolidinone antibiotics.
Diekema DJ; Jones RN
Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
[TBL] [Abstract][Full Text] [Related]
7. Linezolid: an oxazolidinone antimicrobial agent.
Fung HB; Kirschenbaum HL; Ojofeitimi BO
Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Steckelberg JM
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
[TBL] [Abstract][Full Text] [Related]
9. Linezolid: a review of its use in the management of serious gram-positive infections.
Perry CM; Jarvis B
Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Hachem R; Afif C; Gokaslan Z; Raad I
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
[No Abstract] [Full Text] [Related]
11. [Update of antimicrobial resistance in Gram-positive microorganisms].
Cercenado E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
[TBL] [Abstract][Full Text] [Related]
12. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
Ho PL; Ng TK; Yung RW; Que TL; Yip EK; Tse CW; Yuen KY
J Antimicrob Chemother; 2001 Oct; 48(4):590-2. PubMed ID: 11581246
[No Abstract] [Full Text] [Related]
13. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
14. A review of linezolid: the first oxazolidinone antibiotic.
Stevens DL; Dotter B; Madaras-Kelly K
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):51-9. PubMed ID: 15482171
[TBL] [Abstract][Full Text] [Related]
15. Linezolid, the first oxazolidinone antibacterial agent.
Leach KL; Brickner SJ; Noe MC; Miller PF
Ann N Y Acad Sci; 2011 Mar; 1222():49-54. PubMed ID: 21434942
[TBL] [Abstract][Full Text] [Related]
16. Linezolid: pharmacokinetic characteristics and clinical studies.
Bouza E; Muñoz P
Clin Microbiol Infect; 2001; 7 Suppl 4():75-82. PubMed ID: 11688537
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus.
Swenson JM; Tenover FC
J Antimicrob Chemother; 2002 May; 49(5):845-50. PubMed ID: 12003982
[TBL] [Abstract][Full Text] [Related]
18. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].
Blatun LA
Antibiot Khimioter; 2002; 47(2):38-46. PubMed ID: 12087723
[No Abstract] [Full Text] [Related]
20. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Ross JE; Fritsche TR; Sader HS; Jones RN
Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
